CD4 and neoplasm: Thus, we investigated whether direct MHC-II-restricted tumor recognition by our TR-CD4 is solely mediated by their TCR and whether large numbers of TR-CD4 could be generated by gene-engineering with tumor-recognizing MHC-II-restricted TCR.